Navigation Links
Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event
Date:11/9/2012

SAN DIEGO, Nov. 9, 2012 /PRNewswire/ -- The CEO of Verum.de (Verum), a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif. will speak at an upcoming event held by BIOCOM, the large regional life science association, on Tuesday, Nov. 13, 2012 at 7:30 a.m. PST. The session, Legal and Regulatory Update - Health Care Reform and FDA Developments, will feature Verum CEO Christian Sacher presenting about the clinical trial approval process in the European Union and the proposed changes to the EU trial regulations.

(Logo: http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)

Verum joined BIOCOM earlier this year to expand awareness of its flexible and responsive services and its ability to run clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. With more than 25 years experience running clinical trials in Eastern Europe, Sacher is considered a pioneer in the industry. He helped bring ethical committees and Western best practices to trials in the region.

"It is an honor to have the opportunity to speak at BIOCOM as the organization mirrors Verum's values regarding clinical trials," says Christian Sacher. "With both FDA and European regulations constantly changing, we need to help biotech, pharma and device companies stay on top of the latest developments."

Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials. The new office is headed by Kristi Clark, an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.

About Verum.de

German-based Verum.de was founded by Christian Sacher and Jutta Minkner (CFO), two industry pioneers with more than 25 years experience running clinical trials in CEE and former Soviet bloc countries. Verum has more than 100 office based employees operating out of eight locations, including its Munich headquarters, and the company offers therapeutic specialties in cardiovascular, neurology, psychiatry, CNS, oncology and pain, among others. Verum started operations in 1992 in CEE countries based on Western ideals and ethical standards. Verum has substantial contacts with local authorities, and is known in CEE for the flexible and responsive services it provides. More information can be found at http://www.verum.de

CONTACT:

Antonia Genov
Clearpoint Agency, for Verum.de
antonia@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Verum.de
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. German-based Contract Research Organization Verum.de Opens US Office to Expand Clinical Study Services in Central and Eastern Europe for American Pharma and Biotech
2. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
3. Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting
4. Cempra, Inc. to Present at the Jefferies 2012 Global Healthcare Conference in London
5. BioMed Realty To Audio Webcast Company Presentation At Investor Day 2012
6. ProNAi Expands Management Team and Presents Encouraging Phase I Study Results for Lead Cancer Drug at Cancer Meeting
7. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
8. Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference
9. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
10. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/3/2016)... May 3, 2016 BioNovus Innovations LLC ... for Advancing Medical Innovation (IAMI) today announced a ... diagnostics and medical devices. An agreement ... rights to license, develop and commercialize medical innovations ... "This partnership represents a significant advance in ...
(Date:5/3/2016)... ACME Markets, Delaware ... Delaware County Councilman Dave White announced ... ACME pharmacies across Delaware County ... Prevention (CDC), naloxone has saved 26,463 lives nationwide over the past ... Delaware County were authorized to administer naloxone to overdose ...
(Date:5/3/2016)... FLINT, Mich. , May 3, 2016   Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today ... The company released a video of two patients who tell their personal story and encourage ... hepatitis.   Meet Jacque: Hepatitis C ... ... Diplomat Specialty Pharmacy (PRNewsFoto/Diplomat Pharmacy, Inc.) ...
Breaking Medicine Technology:
(Date:5/4/2016)... ... 2016 , ... Qualitative research, which is primarily based on ... of the program, policy or intervention being studied. Both quantitative and qualitative research ... In a new brief released today, Reading Qualitative Educational Policy Research, William Mathis ...
(Date:5/4/2016)... ... May 04, 2016 , ... ... provide the playing surface for the 2016 NCAA Men’s National Collegiate ... for the men’s volleyball championship to be held May 5-7 at Pennsylvania State ...
(Date:5/4/2016)... ... May 04, 2016 , ... Level 10 Head Over Heels Athletic ... to the University of Arizona for the fall of 2019. , After a ... Brovedani’s commitment to the GymCats came from her connection with the coaching staff and ...
(Date:5/4/2016)... New York, NY (PRWEB) , ... May 04, ... ... country’s leading private owners, developers and operators of commercial real estate proudly announced ... its 2015 Heart Health initiative. Team members portfolio-wide will continue Olshan Properties’ ...
(Date:5/4/2016)... ... 04, 2016 , ... A new collaboration will give more researchers access to ... (DCRI) and analytics leader SAS will provide researchers worldwide with data management and analytics ... Health System. , The DCRI and SAS share the goal of greater transparency ...
Breaking Medicine News(10 mins):